Centessa obtains waiver for subsidiary name-change default on Note Purchase Agreement

Centessa Pharmaceuticals plc

On Dec 22, 2022, Centessa entered a waiver with lenders for an Event of Default under the Oct 1, 2021 Note Purchase Agreement.
Default triggered by failure to provide prior written notice of a subsidiary's legal name change on Nov 22, 2022.
Waiver from Three Peaks Capital Solutions Aggregator Fund and Cocoon SA LLC (Oberland Capital affiliate) avoids loan acceleration and penalties.
Without waiver, lenders could have accelerated the loan under the Note Purchase Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.